Company Overview

Cerimon Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the development and commercialization of therapeutics in the areas of inflammation and pain. The Company currently has two drugs in development, a topical patch formulation of diclofenac sodium for the treatment of musculoskeletal pain and a topical lotion formulation of diclofenac sodium for the treatment of osteoarthritis pain.

The Company's name is derived from a character in Shakespeare's play Pericles. Cerimon was a kindly physician who miraculously healed his patients. The Cerimon name symbolizes the Company's desire to provide patients with therapeutics that address today's unmet medical needs.

Cerimon is financed by the premier investors MPM Capital, Nomura Phase4 Ventures, OrbiMed Advisors and Stanford University.